Cargando…
Clinical efficacy and safety of rituximab with membranous nephropathy: a meta-analysis
INTRODUCTION: Membranous nephropathy (MN) is an organ-specific autoimmune disease, and its prevalence is increasing. B lymphocytes activated by T cells produce antibodies. CD19+/CD20+ plasma cells may contribute to autoantibody and alloantibody production. Rituximab has been effective in treating MN...
Autores principales: | Zhong, Hongzhen, Li, Hong-Yan, Zhou, Tianbiao, Zhong, Zhiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074182/ https://www.ncbi.nlm.nih.gov/pubmed/37034519 http://dx.doi.org/10.5114/aoms.2020.99899 |
Ejemplares similares
-
Rituximab therapy in adults with steroid-dependent nephrotic syndrome
por: Zhong, Hongzhen, et al.
Publicado: (2019) -
Clinical efficacy and safety of rituximab in lupus nephritis
por: Zhong, Zhiqing, et al.
Publicado: (2019) -
Efficacy and safety of rituximab for minors with immune thrombocytopenia: a systematic review and meta-analysis
por: Qu, Min, et al.
Publicado: (2020) -
Efficacy and safety of antifibrinolytic agents in spinal surgery: a network meta-analysis
por: Yuan, Lei, et al.
Publicado: (2019) -
Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis
por: Li, Hong-Yan, et al.
Publicado: (2019)